STUART, Fla., Dec. 14 /PRNewswire-FirstCall/ -- Liberator Medical Holdings, Inc. (OTC Bulletin Board: LBMH.OB) reported today that the Company has surpassed its projected November 2007 sales, which is thus far the highest sales month for the Company. Management attributes the result to the Company's ongoing continuous targeted advertising effort.
Mark Libratore, Chief Executive Officer, stated, "Based on our November sales, we believe that in our first fiscal quarter ending December 31, 2007, our Company will have a record sales quarter with sales approximately 63% greater than in our prior quarter. We have now maintained double digit sales growth for four consecutive months."
About Liberator Medical Holdings, Inc.
Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc. established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. As an Exemplary Provider Accredited by The Compliance Team, the Company's unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Approximately 75% of its revenue comes from supplying products to meet the rapidly growing requirements of general medical supplies, personal mobility aids, diabetes, urological, ostomy and mastectomy patients. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.
Safe Harbor Statement
Certain statements in this press release that are not historical, but are forward-looking, and are subject to known and unknown risks and uncertainties which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this press release. Such risks and uncertainties may include, but are not limited to, the Company's need to raise equity capital and its ability to obtain equity financing on acceptable terms, if at all, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, and the risk of early obsolescence of our products. Further, Liberator Holdings is a development stage company that operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond the Company's control, such as announcements and product development by competing product and service providers.
|SOURCE Liberator Medical Holdings, Inc.|
Copyright©2007 PR Newswire.
All rights reserved